GO:0140914 zinc ion import into secretory vesicle

Zinc is an essential trace element that serves as a cofactor for thousands of proteins and plays critical roles in cellular signaling, immunity, and neurotransmission. While zinc is abundant in the cytosol, its concentration within organelles is tightly controlled. One key organellar pool is the zinc stored within secretory vesicles, which are membrane-bound compartments that release their contents upon fusion with the plasma membrane. The process by which zinc is actively transported from the cytosol into these vesicles is annotated as GO:0140914, zinc ion import into secretory vesicle. This biological process is fundamental for loading vesicles with zinc, ensuring that zinc-dependent enzymes and signaling molecules are properly activated upon secretion. Researchers study this process to understand how cells regulate zinc homeostasis and how defects contribute to disease. The import of zinc into secretory vesicles is mediated by specific transporters that couple zinc movement to a proton gradient or other energy sources. In this article, we provide a comprehensive overview of GO:0140914, covering its definition, molecular players, regulatory mechanisms, disease associations, and the experimental methods used to investigate it.

GO:0140914, zinc ion import into secretory vesicle, is defined as the directed import of zinc(2+) from the cytosol, across an organelle membrane, into a secretory vesicle. This process requires the activity of transporter proteins that facilitate the movement of zinc ions against a concentration gradient, often utilizing the proton motive force or ATP hydrolysis. The term encompasses the entire pathway from zinc recognition at the cytosolic face to its release into the vesicular lumen.

Zinc import into secretory vesicles is crucial for diverse physiological processes, including neurotransmission, hormone secretion, and immune regulation. In the brain, vesicular zinc modulates synaptic activity and is involved in learning and memory. In pancreatic beta cells, zinc is co-secreted with insulin and is essential for insulin crystallization and storage. Disruption of vesicular zinc import has been implicated in neurodegenerative diseases such as Alzheimer's disease and epilepsy, as well as in diabetes and certain cancers. Therefore, understanding the molecular mechanisms of GO:0140914 provides insights into both normal physiology and disease pathogenesis.

The following genes encode proteins that are directly involved in or regulate zinc ion import into secretory vesicles.

The process of zinc ion import into secretory vesicles is regulated at multiple levels. Transcriptional regulation of zinc transporter genes, such as SLC30A2 and SLC30A3, controls the abundance of transporters in the vesicle membrane. Post-translational modifications, including phosphorylation and ubiquitination, can modulate transporter activity and trafficking. Additionally, cytosolic zinc levels themselves can feedback on transporter function, ensuring homeostatic control. Hormonal signals, such as insulin and prolactin, can stimulate zinc import into vesicles in pancreatic beta cells and mammary epithelial cells, respectively. In neurons, synaptic activity influences ZnT3 expression and vesicular zinc content.

Dysregulation of zinc import into synaptic vesicles has been implicated in Alzheimer's disease, where altered zinc homeostasis contributes to amyloid-beta aggregation and synaptic dysfunction. In epilepsy, excessive vesicular zinc release may exacerbate excitotoxicity. Mutations in SLC30A3 (ZnT3) have been associated with cognitive impairment in animal models.

SLC30A8 (ZnT8) is a major susceptibility gene for type 2 diabetes. It encodes a zinc transporter that imports zinc into insulin secretory vesicles in pancreatic beta cells. Loss-of-function mutations in SLC30A8 impair insulin secretion and increase diabetes risk. ZnT8 is also an autoantigen in type 1 diabetes.

Altered expression of zinc transporters, including SLC30A2 and SLC30A4, has been observed in breast and prostate cancers. Changes in vesicular zinc import may affect zinc-dependent signaling pathways that promote tumor growth or survival. However, the exact mechanisms remain under investigation.

Mutations in SLC30A10 cause hypermanganesemia with dystonia, polycythemia, and cirrhosis, highlighting the importance of zinc transporters in metal homeostasis. In mammary glands, defects in ZnT2 lead to low zinc in milk, causing severe zinc deficiency in infants.

Fluorescent sensors such as ZapCY and eCALWY can be targeted to secretory vesicles to monitor real-time zinc import. These sensors undergo conformational changes upon zinc binding, altering their fluorescence. They enable live-cell imaging of zinc dynamics with high spatial and temporal resolution.

Small-molecule dyes like FluoZin-3 and TSQ can be used to detect vesicular zinc after cell permeabilization or in isolated vesicles. These dyes are valuable for quantifying total vesicular zinc content. However, they lack the specificity of genetically encoded sensors.

CRISPR-Cas9 allows for the generation of knockout, knock-in, and point-mutation models to study the function of zinc transporters. Knockout of SLC30A genes can reveal their necessity for vesicular zinc import. Knock-in of disease-associated mutations can model human disorders.

Mass spectrometry-based proteomics can identify proteins that co-purify with vesicular zinc transporters. Proximity labeling techniques such as BioID can map the interactome of transporters in living cells. These approaches help uncover regulatory partners and trafficking machinery.

Researchers studying zinc ion import into secretory vesicle-related genes often need to determine whether a candidate gene is causally involved in vesicular zinc loading, how mutations affect transporter function, and what downstream pathways are altered. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.

GO:0140914, zinc ion import into secretory vesicle, is a fundamental biological process that ensures proper zinc loading of secretory vesicles for diverse physiological functions. The transporters and regulatory mechanisms involved are critical for neurotransmission, hormone secretion, and immune responses, and their dysfunction contributes to major human diseases. Continued research using advanced CRISPR models and zinc sensors will further elucidate the molecular details and therapeutic potential of targeting vesicular zinc import.